MetLife Issues $1 Billion Debentures Rated 'bbb+'

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Feb 26 2026

0mins

MET-0.24%

Should l Buy MET?

Source: Newsfilter

Debt Issuance Size: MetLife has successfully issued $1 billion in subordinated debentures at a 5.85% interest rate, which is expected to be utilized for general business purposes, thereby enhancing the company's capital structure and supporting future business expansion.
Stable Credit Rating: AM Best assigned a long-term credit rating of 'bbb+' to this debt issuance, indicating MetLife's robustness in the current market environment, while all other ratings remain unchanged, reflecting the company's overall financial health.
Financial Leverage Situation: MetLife's proforma adjusted financial leverage and historical interest coverage align with its current ratings, demonstrating effective debt management that helps bolster investor confidence in the company's financial stability.
Strong Liquidity: The holding company of MetLife exhibits strong liquidity, which secures its future financing activities and further solidifies its market position within the insurance industry.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy MET?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on MET

Wall Street analysts forecast MET stock price to rise

12 Analyst Rating

11 Buy

1 Hold

0 Sell

Strong Buy

Current: 70.770

Low

84.00

Averages

95.25

High

108.00

Current: 70.770

Low

84.00

Averages

95.25

High

108.00

Morgan Stanley

Bob Huang

Overweight

downgrade

$101 -> $93

2026-03-03

Reason

Morgan Stanley

Bob Huang

Price Target

$101 -> $93

AI Analysis

2026-03-03

downgrade

Overweight

Reason

Morgan Stanley analyst Bob Huang lowered the firm's price target on MetLife to $93 from $101 and keeps an Overweight rating on the shares. The firm is updating its price targets for Insurance - Life/Annuity North America stocks under its coverage, the analyst tells investors. While Morgan Stanley is not concerned about life insurers' exposure to private credit, the broader industry will likely feel pressure on their valuation.

Wells Fargo

Elyse Greenspan

Overweight -> Overweight

downgrade

$97 -> $93

2026-02-25

Reason

Wells Fargo

Elyse Greenspan

Price Target

$97 -> $93

2026-02-25

downgrade

Overweight -> Overweight

Reason

Wells Fargo analyst Elyse Greenspan lowered the firm's price target on MetLife to $93 from $97 and keeps an Overweight rating on the shares. With guidance from most companies in Q4, the firm is generally reducing its EPS estimates as guides were in-line to below consensus expectations for most companies. Wells is also rolling valuation methodologies to 2027 EPS and rolling out new 2028E EPS estimates for companies.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MET

Unlock Now

About MET

MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

MetLife Inc. Gets Unsolicited Mini-Tender Proposal from Potemkin Limited to Acquire Up to 10,000 Shares

10 hours agomoomoo

Company Announcement: Metlife Inc. has received an unsolicited mini-tender offer from Potemkin Limited.
Offer Details: The offer is for the purchase of up to 10,000 shares of Metlife Inc. stock.

VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR SET TO ENTER S&P 500

3 days agomoomoo

New Additions to S&P 500: Vertiv Holdings, Lumentum Holdings, Coherent, and Echosstar are set to join the S&P 500 index.
Market Impact: The inclusion of these companies may influence market dynamics and investor strategies as they become part of a major stock index.

VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR TO BE ADDED TO S&P 500; ADDITIONAL COMPANIES TO ENTER S&P 100, S&P MIDCAP 400, AND S&P SMALLCAP 600

3 days agomoomoo

New Additions to S&P 500: Vert Holdings, Lumentum Holdings, CohereNT, and EchoStar are set to join the S&P 500 index.
Other Index Changes: Additional companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.

Vertiv, Lumentum, Coherent, and EchoStar Set to Enter S&P 500

4 days agoBarron's

Index Changes: S&P Dow Jones Indices is making significant adjustments to its major stock indexes this month.
New Additions: The changes include the addition of several technology and infrastructure companies.
Removals: Some well-known companies are being removed from the indexes as part of this reshuffling.
Market Impact: These adjustments may influence market dynamics and investor strategies moving forward.